2-Deoxy-D-Glucose (2-DG) as a glycolytic inhibitor in the treatment of retinoblastoma

被引：0
|
作者：
Decatur, Christina [1 ]
Pina, Yolanda [1 ]
Houston, Samuel [1 ]
Cayalcante, Ludimila [1 ]
Shah, Nikesh [1 ]
Murray, Timothy [1 ]
机构：
[1] Bascom Palmer Eye Inst, Miami, FL 33136 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2050
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activation of macrophages by the glycolytic inhibitor 2-deoxy-D-glucose (2-DG): Implications for tumor therapy
    Farooque, Abdullah
    Singh, Saurabh
    Verma, Amit
    Afrin, Farhat
    Adhikari, Jawahar
    Dwarakanath, Bilikere
    [J]. CANCER RESEARCH, 2009, 69
  • [2] INSULIN VERSUS 2-DEOXY-D-GLUCOSE - OR 2-DG OR NOT 2-DG - UNANSWERED QUESTION
    ISENBERG, JI
    [J]. GASTROENTEROLOGY, 1972, 63 (04) : 701 - &
  • [3] Inhibition of Akt Increases the Sensitivity of Acute Lymphoblastic Leukemia (ALL) to the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG)
    Du, Jianfeng
    DeSalvo, Joanna
    Muranen, Antti
    Moraes, Carlos T.
    Barredo, Julio C.
    [J]. BLOOD, 2010, 116 (21) : 1334 - 1335
  • [4] Characterization of the effect of 2-deoxy-D-glucose (2-DG) on the immune system
    Chou, SH
    Kojic, LD
    Messingham, KN
    Cunnick, JE
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 1996, 10 (04) : 399 - 416
  • [5] Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice
    Singh, Saurabh
    Pandey, Sanjay
    Bhatt, Anant Narayan
    Chaudhary, Richa
    Bhuria, Vikas
    Kalra, Namita
    Soni, Ravi
    Roy, Bal Gangadhar
    Saluja, Daman
    Dwarakanath, Bilikere S.
    [J]. PLOS ONE, 2015, 10 (07):
  • [6] HYPOTHERMIA FOLLOWING 2-DEOXY-D-GLUCOSE (2-DG) INJECTION INTO SELECTED HYPOTHALAMIC SITES
    SHIRAISH.T
    MAGER, M
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 408 - 408
  • [7] Targeting inflammation induced carcinogenesis by dietary administration of 2-deoxy-D-glucose (2-DG)
    Pandey, S.
    Singh, S.
    Anang, V.
    Seth, S.
    Bhatt, A. N.
    Manda, K.
    Natarajan, K.
    Dwarakanath, B. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 54 : S21 - S21
  • [8] Optimization of Tumor Radiotherapy Part VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor ModelPart VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor Model
    Rakesh Kumar Sharma
    Surender Singh
    Mahavir Degaonkar
    Partha Raghunathan
    Amarnath Maitra
    Viney Jain
    [J]. Strahlentherapie und Onkologie, 2000, 176 (3) : 135 - 143
  • [9] Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETA T-AG retinal tumors
    Pina, Yolanda
    Houston, Samuel K.
    Murray, Timothy G.
    Koru-Sengul, Tulay
    Decatur, Christina
    Scott, William K.
    Nathanson, Lubov
    Clarke, Jennifer
    Lampidis, Theodore J.
    [J]. CLINICAL OPHTHALMOLOGY, 2012, 6 : 817 - 830
  • [10] Mechanisms of Sensitivity of B-Precursor, T-Lineage and BCR/ABL Positive Acute Lymphoblastic Leukemia (ALL) to the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG)
    Du, Jianfeng
    DeSalvo, Joanna
    Barredo, Julio C.
    [J]. BLOOD, 2009, 114 (22) : 1198 - 1198
12345